Skip to content

Maxlyzer Smart Plus

by Avecon Healthcare Pvt. Ltd.

Ref AVCCA 02

Maxlyzer Smart Plus (AVCCA 02) is an in vitro diagnostic device (EU IVDR Class A; EMDN category chemistry instruments) made by Avecon Healthcare Pvt. Ltd., registered in EUDAMED on 24 Apr 2024 (Basic UDI-DI 890617071AVCCADW), active as of 25 Oct 2026.

Active European Union

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number890617071AVCCADW Basic UDI-DI 89061707100964UDI-DIDate24 Apr 2024RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Device name
Semi Auto Biochemistry Analyzer
Model / reference
AVCCA 02
Primary DI / UDI-DI
89061707100964
Basic UDI-DI
890617071AVCCADW
EMDN code
W02010199 Chemistry instruments - other
Device class
Class A
EU registration type
Standard device
EU market of registration
Cyprus

Manufacturer details

EUDAMED SRN
IN-MF-000040691
Authorised representative
Amstermed B.V. NL-AR-000001971

Similar devices in this category

Other devices filed under CHEMISTRY INSTRUMENTS - OTHER.

Other devices from Avecon Healthcare Pvt. Ltd.

See all devices from Avecon Healthcare Pvt. Ltd. →

Properties

  • Professional testing
  • IVD instrument
Other properties (11, all answered No)